[When cholesterol lowering drugs should not be too expensive. Statins are especially effective in secondary prevention].
Thomas
H P
HP
Medizinischen Poliklinik, Charité, Medizin. Fakultät d. Humboldt-Universität zu Berlin. hans-peter.thomas@charite.de
Kassner
U
U
Steinhagen-Thiessen
E
E
D000924:Anticholesteremic Agents / Q000191:economics* / Q000627:therapeutic use; D003324:Coronary Artery Disease / Q000188:drug therapy / Q000191:economics*; D003362:Cost-Benefit Analysis; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000191:economics* / Q000627:therapeutic use; D012008:Recurrence
D000924:Anticholesteremic Agents; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors